[Effects of barley flake on metabolism of glucose and lipids in the patients with impaired fasting glucose].
OBJECTIVE
To investigate the effects of barley flake (BF) on the glucose-lipid metabolism in patients with impaired fasting glucose (IFG).


METHODS
100 patients with IFG were divided into the oat meal (OM) control group and barley flake experimental group for three months intervention according to randomized controlled trail (RCT). Biochemical indicators, glucose-lipid metabolism related enzymes, the area under curve (AUC) of blood glucose and insulin after oral glucose tolerance test (OGTT) were assessed before and after intervention. In addition, the homeostasis model assessment of insulin resistance (HOMA-IR) was calculated by FBG (mmol/L) x INS (microU/L)/ 22.5.


RESULTS
At the end of the three month active intervention, the mean fasting blood glucose (FBG) and insulin (INS) in the patients with BF treatment decreased by 9.26% (P < 0.001) and 13.37% (P = 0.001) separately compared with that in patients with OM treatment; meanwhile, total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) in patients with BF treatment also decreased by 7.20% (P < 0.001) and 9.42% (P = 0. 002), respectively. Glycosylated hemoglobin (HbA1c), HOMA-IR, total glyceride (TG), Apo-B, the AUC of blood glucose and insulin after OGTT were also significantly decreased separately (P < 0.01 or < 0.05 ). However, statistically significant differences failed to be found in HDL-C, Apo-A, ALP and SOD between these two groups.


CONCLUSIONS
BF had favorable effect on improvement of glucose-lipid metabolism in the patients with impaired fasting glucose.
Department of Nutrition and Food Hygiene, College of Public Health, Harbin Medical University, Harbin 150081, China. bimingxin2006@yahoo.cn
Mingxin
M
Bi
Yucun
Y
Niu
Xue
X
Li
Ying
Y
Li
Changhao
C
Sun
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D002523:Edible Grain; D005215:Fasting / Q000097:blood*; D005260:Female; D001467:Hordeum / Q000737:chemistry*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000178:diet therapy*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D011236:Prediabetic State / Q000097:blood / Q000178:diet therapy*
D001786:Blood Glucose; D008055:Lipids